Ruan, Y., Ruan, Y., Kim, H. N., Ogana, H. A., Wan, Z., Hurwitz, S., . . . Kim, Y. (2021). Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Ruan, Yongsheng, et al. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Ruan, Yongsheng, et al. Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.